Loading... Please wait...
  • My Account
  • Order Status
  • Wish Lists

RDEA-119 5 mg



(BAY-869766; N-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-6-methoxyphenyl}-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide)

Purity > 99.0 %

  CAS Number:   923032-37-5
  Chemical Formula:   C19H20F3IN2O5S
  Molecular Weight:
  572.34 g/mol


RDEA119 is an orally bioavailable potent (IC50 at low nM), selective MEK inhibitor with potential anti-cancer activity. RDEA119 specifically inhibits mitogen-activated protein kinase kinase 1 (MAP2K1 or MAPK/ERK kinase 1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation. MEK, a dual specificity threonine/tyrosine kinase, is a key component of the RAS/RAF/MEK/ERK signaling pathway that regulates cell growth; constitutive activation of this pathway has been implicated in many cancers.

RDEA119 is in phase I/II clinical trials for the treatment of advanced cancer and for the treatment of inflammation.

Free Shipping within the Continental USA

Add to Wish List

Click the button below to add the RDEA-119 5 mg to your wish list.

Let's Stay in Touch

Recently Viewed...

Terms of Service & Privacy Policy | Sitemap | P212121 Company Information

All prices are in USD Copyright 2022 P212121, LLC.